QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cynober, L. Search for Related Content PubMed PubMed Citation Articles by Cynober, L.

---

Supplement: Arginine Metabolism: Enzymology, Nutrition, and Clinical Significance

Ornithine -Ketoglutarate as a Potent Precursor of Arginine and Nitric Oxide: A New Job for an Old Friend^1,2

Biochemistry Laboratory, Hôtel-Dieu Hospital—AP-HP and Laboratory of Biological Nutrition EA 2498, School of Pharmacy, Paris 5 University

³To whom correspondence should be addressed. E-mail: luc.cynober{at}htd.ap-hop-paris.fr.

Ornithine -ketoglutarate (OKG) is a salt formed of 2 molecules of ornithine and 1 -ketoglutarate. Its administration improves nutritional status in chronically malnourished (e.g., elderly) and acutely malnourished patients (especially burn and trauma patients). There is evidence that OKG activity is not the simple addition of the effects of ornithine (Orn) and -ketoglutarate (KG), because the presence of both moieties is required to induce the generation of key metabolites such as glutamine, proline, and arginine (Arg), whereas this does not occur when one or the other is given separately. This observation is related to the fact that the main feature of Orn at the whole-body level is to be metabolized through the Orn aminotransferase-dependent pathway, whereas the simultaneous administration of Orn and KG saturates this pathway, diverting Orn toward metabolism into Arg. For years, OKG activity has been associated with its ability to induce the secretion of anabolic hormones, such as insulin and growth hormone, and to increase glutamine and polyamine synthesis. Recent studies using chemical inhibitors of nitric oxide synthase (NOS) suggest that nitric oxide derived from Arg could be partly involved in OKG activity. The use of genetically modified animals (i.e., knockout for NOS expression) is required to confirm this hypothesis.

KEY WORDS: • ornithine -ketoglutarate • arginine • nitric oxide • burn injury

This article has been cited by other articles:

				F. Navarro, W. A. Gleason, J. M. Rhoads, and R. E. Quiros-Tejeira Short Bowel Syndrome: Epidemiology, Pathophysiology, and Adaptation NeoReviews, July 1, 2009; 10(7): e330 - e338. [Abstract] [Full Text] [PDF]

				L. Cynober Pharmacokinetics of Arginine and Related Amino Acids J. Nutr., June 1, 2007; 137(6): 1646S - 1649S. [Abstract] [Full Text] [PDF]

				M. Zhou and R. G. Martindale Arginine in the Critical Care Setting J. Nutr., June 1, 2007; 137(6): 1687S - 1692S. [Abstract] [Full Text] [PDF]

				K. L. Urschel, C. W. Wilkinson, P. B. Pencharz, and R. O. Ball Coadministration of Ornithine and {alpha}-Ketoglutarate Is No More Effective Than Ornithine Alone As an Arginine Precursor in Piglets Enterally Fed an Arginine-Deficient Diet J. Nutr., January 1, 2007; 137(1): 55 - 62. [Abstract] [Full Text] [PDF]

				V. H. Castellanos, M. D. Litchford, and W. W. Campbell Modular Protein Supplements and Their Application to Long-Term Care Nutr Clin Pract, October 1, 2006; 21(5): 485 - 504. [Abstract] [Full Text] [PDF]